UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by Cullen Investment Group LTD.

Cullen Investment Group LTD. lifted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 74.2% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 5,906 shares of the healthcare conglomerate’s stock after purchasing an additional 2,515 shares during the quarter. Cullen Investment Group LTD.’s holdings in UnitedHealth Group were worth $2,987,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also made changes to their positions in UNH. Kathleen S. Wright Associates Inc. purchased a new stake in UnitedHealth Group in the 3rd quarter worth approximately $27,000. Global Wealth Strategies & Associates grew its position in UnitedHealth Group by 152.4% in the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after acquiring an additional 32 shares during the period. West Financial Advisors LLC acquired a new position in shares of UnitedHealth Group during the third quarter valued at $32,000. RPg Family Wealth Advisory LLC acquired a new stake in UnitedHealth Group in the third quarter worth $37,000. Finally, Quarry LP raised its holdings in shares of UnitedHealth Group by 132.1% during the second quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock worth $33,000 after acquiring an additional 37 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Up 4.0 %

UNH stock opened at $541.28 on Tuesday. The company’s 50 day moving average price is $554.92 and its two-hundred day moving average price is $562.88. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The company has a market capitalization of $498.13 billion, a PE ratio of 35.26, a price-to-earnings-growth ratio of 1.53 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. During the same period in the previous year, the firm earned $6.56 EPS. The business’s quarterly revenue was up 9.2% on a year-over-year basis. As a group, analysts predict that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.55%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s payout ratio is 54.72%.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on UNH shares. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Monday, December 9th. Piper Sandler dropped their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research report on Thursday, January 2nd. Barclays raised their price objective on shares of UnitedHealth Group from $603.00 to $655.00 and gave the company an “overweight” rating in a report on Wednesday, November 27th. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target for the company in a research note on Friday. Finally, Truist Financial lowered their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Two equities research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus target price of $626.79.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.